Drug intelligence / Profile preview

microRNA-199a

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, miRNA Mimics → MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Topical
01

Overview

microRNA-199a (miR-199a) is a highly conserved microRNA family that plays a critical role in regulating gene expression post-transcriptionally across various physiological and pathological contexts, including oncology, cardiovascular disease, and metabolic disorders. It exists as two mature strands, miR-199a-3p and miR-199a-5p, which target distinct sets of mRNAs. In therapeutic development, synthetic miR-199a mimics are investigated for their ability to restore downregulated levels in diseases like hepatocellular carcinoma and ischemic stroke, where they often act as tumor suppressors or neuroprotective agents. Conversely, antagomirs or inhibitors targeting miR-199a are explored for conditions where the microRNA is overexpressed, such as in certain models of insulin resistance. miR-199a modulates key signaling pathways, including the PI3K/Akt/mTOR and NF-κB cascades, by directly binding to the 3' untranslated regions of target genes such as SIRT1, SCD1, and DDIT4.

Other names
microRNA 199amicroRNA199amicroRNA-199a
02

Targets

SIRT1 (NAD-dependent protein deacetylase sirtuin-1)FZD4 (Frizzled class receptor 4)HIF1A (Hypoxia-inducible factor 1-alpha)WNT2 (Wnt family member 2)JAG1 (Jagged-1 protein)

Beyond the preview

Go deeper on microRNA-199a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-199a.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call